Danaher Corporation

General ticker "DHR" information:

  • Sector: Health Care
  • Industry: Life Sciences Tools & Services
  • Capitalization: $177.8B (TTM average)

Danaher Corporation follows the US Stock Market performance with the rate: 16.5%.

Estimated limits based on current volatility of 1.6%: low 189.95$, high 196.01$

Factors to consider:

  • Company included in S&P500 list
  • Company pays dividends (quarterly): last record date 2025-03-28, amount 0.32$ (Y0.67%)
  • China accounted for 11.7% of revenue in the fiscal year ended 2024-12-31
  • US accounted for 41.6% of revenue in the fiscal year ended 2024-12-31
  • Earnings for 3 months up through Q1 are below our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2024-12-31 to 2026-12-31

  • 2024-12-31 to 2025-12-31 estimated range: [204.38$, 274.32$]
  • 2025-12-31 to 2026-12-31 estimated range: [194.24$, 265.40$]

Financial Metrics affecting the DHR estimates:

  • Positive: Non-GAAP EPS, $ of 7.49 > 2.19
  • Negative: Industry earnings per price (median), % of -0.96 <= 0
  • Positive: 2.69 < Return on assets ratio (scaled to [-100,100]) of 4.79
  • Positive: -3.20 < Investing cash flow per share, $ of -2.69
  • Negative: negative Industry operating income (median)
  • Negative: 0.10 < Interest expense per share, $ of 0.38
  • Negative: Inventory ratio change, % of 4.38 > 1.05

Similar symbols

Short-term DHR quotes

2025-03-282025-03-312025-04-012025-04-022025-04-032025-04-042025-04-072025-04-082025-04-092025-04-102025-04-112025-04-142025-04-152025-04-162025-04-172025-04-212025-04-222025-04-232025-04-242025-04-252025-04-282025-04-292025-04-302025-05-012025-05-022025-05-052025-05-062025-05-072025-05-082025-05-09170175180185190195200205210
Price $

Long-term DHR plot with estimates

180200220240260280300320Jul 2023Jan 2024Jul 2024Jan 2025Jul 2025Jan 2026Jul 2026Jan 202700.511.52
DHRS&P500Health CareNon-GAAP EPS EstimateNon-GAAP EPS ActualPrice $Non-GAAP EPS $

Financial data

YTD 2022-12-31 2023-12-31 2024-12-31
Operating Revenue $26,643.00MM $23,890.00MM $23,875.00MM
Operating Expenses $19,107.00MM $18,688.00MM $19,012.00MM
Operating Income $7,536.00MM $5,202.00MM $4,863.00MM
Non-Operating Income $-390.00MM $-158.00MM $-217.00MM
Interest Expense $204.00MM $286.00MM $278.00MM
R&D Expense $1,528.00MM $1,503.00MM $1,584.00MM
Income(Loss) $7,146.00MM $5,044.00MM $4,646.00MM
Taxes $818.00MM $823.00MM $747.00MM
Other Income(Loss) $881.00MM $543.00MM $0.00MM
Profit(Loss)* $7,209.00MM $5,307.00MM $3,899.00MM
Stockholders Equity $50,082.00MM $53,486.00MM $49,543.00MM
Inventory $3,110.00MM $2,594.00MM $2,330.00MM
Assets $84,350.00MM $84,488.00MM $77,542.00MM
Operating Cash Flow $8,519.00MM $7,164.00MM $6,688.00MM
Capital expenditure $1,152.00MM $1,383.00MM $1,392.00MM
Investing Cash Flow $-2,234.00MM $-7,081.00MM $-1,981.00MM
Financing Cash Flow $-2,570.00MM $-273.00MM $-8,385.00MM
Earnings Per Share** $9.94 $7.21 $5.33

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.